Search

Called NEXT, the factor plays an important role in handing over RNA to the exosome for destruction.

… Thursday, June 9, 2022 In biology, getting rid of stuff can be just as important as making it. A buildup of cells, proteins, or other molecules that are no longer needed can cause problems, so living things have evolved several ways to clean house. A prime example is the RNA exosome. RNA molecules perform

Learn about MSK’s visionary new cancer engineering PhD Program.

… Tuesday, August 22, 2023 Memorial Sloan Kettering Cancer Center (MSK) is substantially expanding its commitment to train the next generation of scientists through a first-of-its-kind PhD program that offers researchers with an engineering, physical science, and computational focus the chance to see their

MSK researchers are learning more about how cancer cells can survive undetected for years only to return in new places. These insights will guide future therapies.

… Thursday, July 1, 2021 For every windsurfing dandelion seed that lands in a nurturing spot and sprouts a new weed, perhaps a thousand more will fall on hostile ground or be trampled under foot. Something similar happens in cancer, which explains why one of the most famous ways of thinking about its spread

After 21 years of dedicated service, Elizabeth McCormick, MSN, RN, CENP, Senior Vice President, Chief Nursing Officer and Enid A. Haupt Chair, Department of Nursing, will retire from MSK at the end of 2021. During her tenure, Ms. McCormick transformed and ultimately redefined the role of nursing at MSK.

… Wednesday, June 30, 2021 Elizabeth McCormick, Senior Vice President and Chief Nursing Officer was given a surprise retirement celebration by MSK staff. Elizabeth McCormick, Senior Vice President and Chief Nursing Officer was given a surprise retirement celebration by MSK staff. After 21 years of dedicated

Researchers at Memorial Sloan Kettering are developing a new strategy for PET imaging of tumors that could result in new tools to detect and monitor prostate cancer.

… Thursday, November 15, 2012 Summary Researchers at Memorial Sloan Kettering are developing a new strategy for PET imaging of tumors that could result in new tools to detect and monitor prostate cancer. A Memorial Sloan Kettering research team is developing a medical imaging agent that could result in

The effects of adoptive T cell therapy on mesothelioma and metastatic lung and breast cancers are the focus of a new Memorial Sloan Kettering Cancer Center trial, which, compared to some existing trials of therapy, offers some important differences for patients.

… Friday, September 23, 2016 The Thoracic Surgery Service at Memorial Sloan Kettering Cancer Center (MSK) is excited to announce the opening of a new clinical trial that uses an adoptive T cell therapy approach to treat mesothelioma and metastatic lung and breast cancers. The CAR T Cell Immunotherapy Breakthrough

Maria Jasin, a member of the Sloan Kettering Institute’s Developmental Biology Program, discusses her research.

… Wednesday, September 25, 2019 Summary Biologist Maria Jasin discusses her work on DNA repair and why the Sloan Kettering Institute is such a great place to do research. On September 25, Sloan Kettering Institute researcher Maria Jasin was presented with the Shaw Prize in Life Science and Medicine at

This year, the GSK student-run Experimental Therapeutics Symposium highlighted MSK’s expertise in successfully moving novel therapies from bench to bedside.

… Monday, November 7, 2016 Attendees of the Experimental Therapeutics Symposium came from the five former Howard Hughes Medical Institute Med into Grad grant recipient institutions. Attendees of the Experimental Therapeutics Symposium came from the five former Howard Hughes Medical Institute Med into Grad

A new lung cancer research center has been created at Memorial Sloan Kettering Cancer Center (MSK). The Fiona and Stanley Druckenmiller Center for Lung Cancer Research (DCLCR) is a multidisciplinary research initiative dedicated to developing innovative and more-effective treatments for people with lung cancer.

… Thursday, July 9, 2015 A new lung cancer research center has been created at Memorial Sloan Kettering Cancer Center (MSK).  The Fiona and Stanley Druckenmiller Center for Lung Cancer Research (DCLCR) is a multidisciplinary research initiative dedicated to developing innovative and more-effective treatments

A protein detected in the urine of children with Wilms’ tumor led to the development of a test to improve diagnosis and treatment.

… Thursday, August 8, 2019 Summary Wilms’ tumor is the most common kidney cancer in children. Researchers have detected a protein called prohibitin in the urine of people with aggressive Wilms’ tumor. This discovery could help doctors identify people at risk for the cancer returning after treatment and